Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
13 13 Search
2025
COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity
Journal of Translational Medicine
2025
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function
Cancer Immunology, Immunotherapy
2025
MONet: cancer driver gene identification algorithm based on integrated analysis of multi-omics data and network models
Experimental Biology and Medicine
2024
Differential expression analysis identifies a prognostically significant extracellular matrix–enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma
Scientific Reports
2024
The lncRNA Signature Associated with Basement Membrane as a Novel Biomarker of Prognostic Significance and Identification for Clear Cell Renal Cell Carcinoma
Advances in Clinical Medicine
2024
Interpretable AI models for predicting distant metastasis development based on genetic data: Kidney cancer example
BIO Web of Conferences
2024
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease
Endocrine Reviews
2024
Radix Actinidiae chinensis induces the autophagy and apoptosis in renal cell carcinoma cells
European Journal of Medical Research
2024
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma
PLOS ONE
2024
P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway
Pathology - Research and Practice
2023
SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma
Journal of Oncology
2023
Prediction of Distant Metastases in Patients with Kidney Cancer Based on Gene Expression and Methylation Analysis
Diagnostics
2022
Evaluation of antimicrobial, anticancer potential and Flippase induced leakage in model membrane of Centella asiatica fabricated MgONPs
Biomaterials Advances